RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
-3.83%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$928M
AUM Growth
+$928M
(-2.2%)
Cap. Flow
+$42.1M
Cap. Flow
% of AUM
4.54%
Top 10 Holdings %
Top 10 Hldgs %
34.27%
Holding
87
New
4
Increased
25
Reduced
17
Closed
2
Top Buys
| 1 |
Eli Lilly
LLY
|
$10.2M |
| 2 |
Charles River Laboratories
CRL
|
$8.62M |
| 3 |
Procept Biorobotics
PRCT
|
$7.02M |
| 4 |
Intuitive Surgical
ISRG
|
$6.87M |
| 5 |
Medtronic
MDT
|
$6.5M |
Top Sells
| 1 |
Cigna
CI
|
$10M |
| 2 |
Zimmer Biomet
ZBH
|
$8.75M |
| 3 |
Elevance Health
ELV
|
$7.84M |
| 4 |
UnitedHealth
UNH
|
$7.06M |
| 5 |
Molina Healthcare
MOH
|
$6.54M |
Sector Composition
| 1 | Healthcare | 99.51% |
| 2 | Industrials | 0.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Relay Therapeutics
RLAY
$709M
| $1.6M | 0.17% |
190,000
| – | – |
|
77
Intellia Therapeutics
NTLA
$1.26B
| $1.58M | 0.17% |
50,000
| – | – |
|
78
Inspire Medical Systems
INSP
$2.53B
| $1.39M | 0.15% |
7,000
-8,400
| -55% | -$1.67M |
|
79
TG Therapeutics
TGTX
$5.03B
| $1.34M | 0.14% |
160,000
+105,000
| +191% | +$878K |
|
80
INmune Bio
INMB
$52.4M
| $1.22M | 0.13% |
178,284
| – | – |
|
81
ESSA Pharma
EPIX
$11.2M
| $1.1M | 0.12% |
356,500
| – | – |
|
82
Allogene Therapeutics
ALLO
$249M
| $951K | 0.1% |
300,000
| – | – |
|
83
Outset Medical
OM
$245M
| $544K | 0.06% |
50,000
-280,635
| -85% | -$3.05M |
|
84
Mersana Therapeutics
MRSN
$34.8M
| $508K | 0.05% |
400,000
| – | – |
|
85
Thermo Fisher Scientific
TMO
$183B
| $253K | 0.03% |
500
| – | – |
|
86
Rigel Pharmaceuticals
RIGL
$710M
| – | – |
-253,832
| Closed | -$327K |
|
|
87
Molina Healthcare
MOH
$9.6B
| – | – |
-21,700
| Closed | -$6.54M |
|